Beta Bionics (BBNX) News
NASDAQ: BBNXHealth CareMedical/Dental InstrumentsUSD
17.63+0.20 (+1.15%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
BBNX news summary
We found 5 recent headlines mentioning Beta Bionics (BBNX): 4 in the past week and 5 in the past 30 days, most often from PR Newswire, Nasdaq. For price context, BBNX is up 1.15% at $17.63. The most recent story, "Beta Bionics, Inc. Notice of November 3, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline", was published by PR Newswire on Oct 9, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Beta Bionics headlines
- Beta Bionics, Inc. Notice of November 3, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application DeadlineNEW YORK and NEW ORLEANS, Oct. 9, 2026 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Beta Bionics,…PR Newswire
- BBNX Investors Have Opportunity to Lead Beta Bionics, Inc. Securities Fraud LawsuitNEW YORK, Oct. 8, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Beta Bionics, Inc. (NASDAQ: BBNX) between July 30, 2025 and…PR Newswire
- BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action LawsuitLOS ANGELES, Oct. 8, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP, a national shareholder rights litigation firm, announces that it has filed a federal securities class action on behalf of…PR Newswire
- Beta Bionics (BBNX) Alert: Securities Class Action Filed, Investors with Losses Encouraged to Contact Hagens Berman Before November 3, 2026 Lead Plaintiff DeadlineSAN FRANCISCO, Oct. 8, 2026 /PRNewswire/ -- Beta Bionics, Inc. (NASDAQ: BBNX) faces a securities class action, which seeks to represent investors who purchased or otherwise acquired shares of the…PR Newswire
- Weekly Buzz: RARE, BAYRY Win Approvals; SION Cuts Jobs, GSK Deals; AZN, RHHBY Lead(RTTNews) - Biotech investors tracked a busy week marked by regulatory approvals, strategic collaborations, workforce restructuring and key clinical trial readouts.NasdaqAEMD, AZN, BBNX, BIIB